Beta Drugs Ltd.

BETA

₹1061.8

-3.64% (-40.1)

Market Cap

₹1,076 Cr.

P/E

25.37

Key Ratios

Edit Ratio's

Market cap

1,076 Cr

25.37

Prom Holding

64.90 %

ROE (%)

21.52

ROCE (%)

20.66

Div Yield (%)

Sales

175 Cr

OPM (%)

20.19 %

Debt to Equity

0.70

Edit Ratio's

About

Beta Drugs, a part of the Adley Group, specializes in developing, manufacturing, and marketing… Read more

Low

1047

52W Range

High

2000

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

10 Yes

Positive for this company

3 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
ROE

Roe has decreased vs 10 year trend
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Beta Drugs Ltd. Business

What does Beta Drugs do?

Beta Drugs, a part of Adley Group, specializes in manufacturing oncology products like anti-cancer tablets, capsules, injections, and lyophilized injections. With a portfolio of over 50 products, it caters to the treatment of various cancer diseases.

Who are the competitors of Beta Drugs?

Beta Drugs major competitors are Ind-Swift Lab., Jagsonpal Pharma, Sakar Healthcare, Venus Remedies, Lincoln Pharma, Syncom Formulations, Fredun Pharma.
Market Cap of Beta Drugs is ₹1,117 Crs.
While the median market cap of its peers are ₹1,122 Crs.

Is Beta Drugs financially stable compared to its competitors?

Beta Drugs seems to be less financially stable compared to its competitors.
Altman Z score of Beta Drugs is 5.21 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Small Cap Consistent Compounders

Small companies which consistently grow their sales , while maintaining healthy return on capital.

Run Query

Oversold on RSI Basis

Stocks with RSI of less than 30.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation					Mar Sep
Conference Call					Mar Sep
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Beta Drugs Ltd.

View The Discussion On Valuepickr

A Thread on Beta Drugs - Mukul Garga

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Beta Drugs Ltd.

Beta Drugs Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

10 Yes

3 Neutral

4 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Retail Holding

Promoter Holding

Revenue Recognition

Price & Performance

Working Capital

Current vs Historic Valuation

Debt

Sales Growth

ROCE Strength

Capex vs ROCE

Balance Sheet Strength

ROE

Share price

Margin Stability

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

Corporate Actions

FAQs on Beta Drugs Ltd. Business

What does Beta Drugs do?

Who are the competitors of Beta Drugs?

Is Beta Drugs financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE